Physician profile
Maged S Hamza
NPI 1871551580
$24,310.15
in general payments reported to CMS, 2019-2025
34 companies · $5,177 in 2025
The $5,177 reported for 2025 was more than what 93% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,887 · 2020: $2,123 · 2021: $696 · 2022: $2,615 · 2023: $2,133 · 2024: $1,679 · 2025: $5,177.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,632 · Honoraria: $4,000 · Travel and Lodging: $357.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,632.34 |
| Honoraria | $4,000.00 |
| Travel and Lodging | $357.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $5,797.20 | 2019-2020 | |
| Medtronic, INC. | $4,603.21 | 2021-2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray, Synchromedii |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $4,100.82 | 2021-2025 | Relistor |
| Piramal Critical Care | $4,066.41 | 2019 | |
| Flowonix Medical Incorporated | $1,738.51 | 2020 | |
| Spr Therapeutics, INC | $984.82 | 2022-2023 | Sprint Pns System |
| Abbott Laboratories | $610.70 | 2021-2025 | Proclaim |
| Spinefrontier, INC. | $402.06 | 2025 | Sijfuse, Inspan, Nanofuse |
| Abbvie INC. | $276.62 | 2022-2023 | |
| Vertos Medical, INC. | $238.08 | 2023 | Mild Device Kit |
| Nevro Corp. | $203.66 | 2019-2022 | |
| Boston Scientific Corporation | $177.15 | 2022-2025 | Intracept |
| Stimwave Technologies Incorporated | $176.77 | 2019 | |
| Relievant Medsystems, INC. | $149.84 | 2021 | |
| Nalu Medical, INC. | $123.78 | 2023 | Nalu Neurostimulation System |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tersera Therapeutics LLC | $112.34 | 2023-2024 | Prialt |
| Spinal Simplicity, LLC | $90.80 | 2023 | Ha Minuteman G3-R |
| Painteq LLC | $90.40 | 2023 | Painteq |
| Virtus Pharmaceuticals LLC | $38.30 | 2025 | Levorphanol Tartrate |
| Alevio, LLC | $36.18 | 2023 | Sicure Sacroiliac Joint Fusion System |
| Si-Bone, INC. | $33.71 | 2024 | |
| Radius Health, INC. | $31.55 | 2021 | |
| Curonix LLC | $30.99 | 2023-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Almatica Pharma LLC | $26.50 | 2021 | |
| Globus Medical, INC. | $24.53 | 2025 | Vyrsa V1 |
| Averitas Pharma INC. | $20.12 | 2025 | Qutenza |
| Arbor Pharmaceuticals, INC. | $19.38 | 2021 | |
| Redhill Biopharma INC. | $17.60 | 2021 | |
| Depuy Synthes Sales INC. | $16.71 | 2021 | |
| Mdd US Operations, LLC | $16.09 | 2020 | |
| Collegium Pharmaceutical, INC. | $15.41 | 2022 | |
| Biodelivery Sciences International, INC. | $15.31 | 2020 | |
| Forte Bio-Pharma LLC | $13.17 | 2024 | Prolate, Nalocet |
| Novartis Pharmaceuticals Corporation | $11.43 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maged Hamza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.